|
1
|
Li QC, Liang Y, Tian Y and Hu GR:
Arctigenin induces apoptosis in colon cancer cells through
ROS/p38MAPK pathway. J BUON. 21:87–94. 2016.PubMed/NCBI
|
|
2
|
Gao XY and Wang XL: An adoptive T cell
immunotherapy targeting cancer stem cells in a colon cancer model.
J BUON. 20:1456–1463. 2015.PubMed/NCBI
|
|
3
|
Gatzidou E, Mantzourani M, Giaginis C,
Giagini A, Patsouris E, Kouraklis G and Theocharis S: Augmenter of
liver regeneration gene expression in human colon cancer cell lines
and clinical tissue samples. J BUON. 20:84–91. 2015.PubMed/NCBI
|
|
4
|
Yu J, Ma X, Cheung KF, Li X, Tian L, Wang
S, Wu CW, Wu WK, He M, Wang M, et al: Epigenetic inactivation of
T-box transcription factor 5, a novel tumor suppressor gene, is
associated with colon cancer. Oncogene. 29:6464–6474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rimkus C, Martini M, Friederichs J,
Rosenberg R, Doll D, Siewert JR, Holzmann B and Janssen KP:
Prognostic significance of downregulated expression of the
candidate tumour suppressor gene SASH1 in colon cancer. Br J
Cancer. 95:1419–1423. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nielsen BS, Jørgensen S, Fog JU, Søkilde
R, Christensen IJ, Hansen U, Brünner N, Baker A, Møller S and
Nielsen HJ: High levels of microRNA-21 in the stroma of colorectal
cancers predict short disease-free survival in stage II colon
cancer patients. Clin Exp Metastasis. 28:27–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Engle SJ, Hoying JB, Boivin GP, Ormsby I,
Gartside PS and Doetschman T: Transforming growth factor beta1
suppresses nonmetastatic colon cancer at an early stage of
tumorigenesis. Cancer Res. 59:3379–3386. 1999.PubMed/NCBI
|
|
9
|
Chen X, Deane NG, Lewis KB, Li J, Zhu J,
Washington MK and Beauchamp RD: Comparison of nanostring
ncounter® data on FFPE colon cancer samples and
affymetrix microarray data on matched frozen tissues. PLoS One.
11:e01537842016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Larsson O, Wahlestedt C and Timmons JA:
Considerations when using the significance analysis of microarrays
(SAM) algorithm. BMC Bioinformatics. 6:1292005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang F, Xiao J, Cong W, Li A, Wei F, Xu J,
Zhang C, Fan Z, He J and Wang S: Stage-specific differential gene
expression profiling and functional network analysis during
morphogenesis of diphyodont dentition in miniature pigs, Sus
Scrofa. BMC Genomics. 15:1032014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: The gene ontology consortium: Gene ontology: Tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wixon J and Kell D: The Kyoto Encyclopedia
of Genes and Genomes-KEGG. Yeast. 17:48–55. 2000.PubMed/NCBI
|
|
14
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Patricia Rios-Ibarra C, Rodriguez-Silva
Janeth C, Lopez-Chuken Alonso Y, Ortiz-Lopez R, Fernandez-Castillo
E, Del Toro Runzer Beatriz C, Armenta-Perez Paul V,
Flores-Gutierrez JP, Quintanilla-Guzman A, Salinas-Santander M, et
al: Thymidylate synthase polymorphism in Mexican patients with
colon cancer treated with 5-fluorouracil. J BUON. 21:935–940.
2016.PubMed/NCBI
|
|
16
|
Kawaguchi K and Morita M: ABC Transporter
Subfamily D: Distinct differences in behavior between ABCD1-3 and
ABCD4 in subcellular localization, function, and human disease.
Biomed Res Int. 2016:67862452016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stein U and Walther W: Reversal of ABC
transporter-dependent multidrug resistance in cancer. Am J Cancer.
5:285–297. 2006. View Article : Google Scholar
|
|
18
|
Hayashi M, Nito K, Takei-Hoshi R, Yagi M,
Kondo M, Suenaga A, Yamaya T and Nishimura M: Ped3p is a
peroxisomal ATP-binding cassette transporter that might supply
substrates for fatty acid beta-oxidation. Plant Cell Physiol.
43:1–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hernlund E, Ihrlund LS, Khan O, Ates YO,
Linder S, Panaretakis T and Shoshan MC: Potentiation of
chemotherapeutic drugs by energy metabolism inhibitors
2-deoxyglucose and etomoxir. Int J Cancer. 123:476–483. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holla VR, Wu H, Shi Q, Menter DG and
DuBois RN: Nuclear orphan receptor NR4A2 modulates fatty acid
oxidation pathways in colorectal cancer. J Biol Chem.
286:30003–30009. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ellis JM, Hasek LY, Yurovich EJ, Harris KL
and Goergen CJ: Mouse carnitine palmitoyltransferase 2 (CPT2) is
required to sustain cardiac function. J FASEB. 30:684–688.
2016.
|
|
22
|
Seelaender MCL, Curi R, Colquhoun A,
Williams JF and Zammitt VA: Carnitine palmitoyltransferase II
activity is decreased in liver mitochondria of cachectic rats
bearing the Walker 256 carcinosarcoma: Effect of indomethacin
treatment. Biochem Mol Biol Int. 44:185–193. 1998.PubMed/NCBI
|
|
23
|
Yeh CS, Wang JY, Cheng TL, Juan CH, Wu CH
and Lin SR: Fatty acid metabolism pathway play an important role in
carcinogenesis of human colorectal cancers by
Microarray-Bioinformatics analysis. Cancer Lett. 233:297–308. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang D and Dubois RN: PPARδ and
PGE2 signaling pathways communicate and connect
inflammation to colorectal cancer. Inflamm Cell Signal. 1:102014.
View Article : Google Scholar
|
|
25
|
Crushell E, Treacy EP, Dawe J, Durkie M
and Beauchamp NJ: Glycogen storage disease type III in the Irish
population. J Inherit Metab Dis. 33 Suppl 3:S215–S218. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guin S, Ru Y, Agarwal N, Lew CR, Owens C,
Comi GP and Theodorescu D: Loss of glycogen debranching enzyme AGL
drives bladder tumor growth via induction of hyaluronic acid
synthesis. Clin Cancer Res. 1:1274–1283. 2016. View Article : Google Scholar
|
|
27
|
Holroyde CP, Skutches CL, Boden G and
Reichard GA: Glucose metabolism in cachectic patients with
colorectal cancer. Cancer Res. 44:5910–5913. 1984.PubMed/NCBI
|
|
28
|
Straus DS: TNFα and IL-17 cooperatively
stimulate glucose metabolism and growth factor production in human
colorectal cancer cells. Mol Cancer. 12:782013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang TW, Chiu HH, Gurney A, Sidle A,
Tumas DB, Schow P, Foster J, Klassen T, Dennis K, DeMarco RA, et
al: Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM
2 interacts with T, NK, and dendritic cells through JAM 3. J
Immunol. 168:1618–1626. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lian S, Meng L, Xing X, Yang Y, Qu L and
Shou C: PRL-3 promotes cell adhesion by interacting with JAM2 in
colon cancer. Oncol Lett. 12:1661–1666. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Royse KE, Liang C, Uriostegui J, Ittmann
M, Graham DY, Hashem ES and Jiao L: Abstract 4591: Differential
expression of tight junction polarity genes in human colon cancer.
Cancer Res. 75:4591. 2015. View Article : Google Scholar
|
|
32
|
Lee S, Huh SJ, Oh SY, Koh MS, Kim SH, Lee
JH, Han JY, Choi HJ, Kim SJ and Kim HJ: Clinical significance of
coagulation factors in operable colorectal cancer. Oncol Lett.
13:4669–4674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Im JH, Fu W, Wang H, Bhatia SK, Hammer DA,
Kowalska MA and Muschel RJ: Coagulation facilitates tumor cell
spreading in the pulmonary vasculature during early metastatic
colony formation. Cancer Res. 64:8613–8619. 2004. View Article : Google Scholar : PubMed/NCBI
|
